Versius手术系统经口机器人手术安全性与有效性前瞻性研究
英国单中心开放标签II期试验纳入62例头颈良恶性病变患者,60例使用Versius系统完成经口机器人手术,全部无中转完成,30天并发症率18.3%且无器械相关,恶性肿瘤切缘阴性率89.3%。
要点
- Versius系统经口机器人手术全部无中转完成,中位建立时间10分钟、手术时间46分钟。
- 30天并发症率18.3%,无器械相关并发症,继发性出血率6.7%。
- 恶性肿瘤切缘阴性率89.3%,T1-T2病变达95.7%。
核心结论
- Versius手术系统在经口机器人手术中展示高手术成功率、低并发症率及与现有机器人平台相当的肿瘤学结果,是安全可行的机器人平台。
主要发现
- 全部60例手术成功完成且无中转。
- 中位建立时间10分钟,中位手术时间46分钟。
- 98%病例估计失血量<100 mL,无输血。
- 中位住院1天,35%同日出院,无患者需鼻胃管喂养。
临床怎么用
- Versius系统可用于经口机器人手术治疗选择性头颈良恶性病变,需关注术后出血风险。
局限性
- 单中心、单臂设计,样本量有限,缺乏与其它机器人平台的直接对照。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the safety and feasibility of the Versius surgical robotic system for transoral robotic surgery in benign and malignant head and neck indications. STUDY DESIGN: Open-label, prospective, single-arm, phase II clinical trial. SETTING: Liverpool Head and Neck Centre, United Kingdom. METHODS: Between December 2023 and March 2025, 62 patients were enrolled, with 60 undergoing transoral robotic surgery on the Versius system. Eligible adults had either confirmed oropharyngeal or unknown primary squamous cell carcinoma, or benign indications (recurrent tonsillitis or peritonsillar abscess). The primary endpoint was successful procedure completion without conversion, and safety was assessed by 30-day complication incidence. Secondary endpoints included operative and setup times, blood loss, length of stay, nasogastric tube use, readmissions, reoperations and margin status in malignant resections. RESULTS: All 60 procedures were completed successfully without conversion. Median setup time was 10 minutes and operative time 46 minutes. Estimated blood loss was <100 mL in 98% of cases, with no transfusions required. Median hospital stay was 1 day, with a 35% same day discharge rate. No patient required nasogastric tube feeding. Eleven postoperative complications occurred (18.3%), none device-related, and a secondary hemorrhage rate of 6.7%. Among 28 oncological resections, 25 (89.3%) achieved negative margins, including 21 of 22 (95.7%) cases with T1-T2 disease. CONCLUSION: The Versius surgical robotic system demonstrated high procedural success, low morbidity and oncological outcomes comparable to established robotic platforms. It represents a safe and feasible robotic platform for integration into a contemporary head and neck transoral surgery practice.
引用
- Fleming JC, Davies K, Loh C, et al. Safety and Efficacy of the Versius Surgical System in Transoral Robotic Surgery: A Prospective Study. Otolaryngol Head Neck Surg. 2026. PMID: 42606094. doi:10.1002/ohn.70402
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。